Although substantial research focused on metabolic changes has improved the understanding of KRAS-mutation-driven cancers, the precise mechanism by which metabolic reprogramming promotes and coordinates KRAS-mutant CRC growth and progression remains to be fully investigated. Here, KRAS is linked to colorectal carcinoma.